These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9704486)

  • 41. Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells.
    Hedlund G; Dohlsten M; Lando PA; Kalland T
    Cell Immunol; 1990 Sep; 129(2):426-34. PubMed ID: 2383900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody.
    Ueno A; Arakawa F; Abe H; Matsumoto H; Kudo T; Asano R; Tsumoto K; Kumagai I; Kuroki M; Kuroki M
    Anticancer Res; 2002; 22(2A):769-76. PubMed ID: 12014649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and In Vitro Evaluation of Antitumor Activity of TGFαL3-SEB as a Ligand-Targeted Superantigen.
    Yousefi F; Mousavi SF; Siadat SD; Aslani MM; Amani J; Rad HS; Fooladi AA
    Technol Cancer Res Treat; 2016 Apr; 15(2):215-26. PubMed ID: 25759426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules.
    Thibodeau J; Labrecque N; Denis F; Huber BT; Sékaly RP
    J Exp Med; 1994 Mar; 179(3):1029-34. PubMed ID: 8113671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T-cell receptor beta-chain binding to enterotoxin superantigens.
    Irwin MJ; Hudson KR; Ames KT; Fraser JD; Gascoigne NR
    Immunol Rev; 1993 Feb; 131():61-78. PubMed ID: 8486394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
    Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
    PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain.
    Thibodeau J; Dohlsten M; Cloutier I; Lavoie PM; Bjork P; Michel F; Léveillé C; Mourad W; Kalland T; Sékaly RP
    J Immunol; 1997 Apr; 158(8):3698-704. PubMed ID: 9103433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Staphylococcal-enterotoxin-dependent cell-mediated cytotoxicity.
    Dohlsten M; Hedlund G; Kalland T
    Immunol Today; 1991 May; 12(5):147-50. PubMed ID: 1878125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
    Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
    Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytotoxic T lymphocyte-dependent tumor growth inhibition by a vascular endothelial growth factor-superantigen conjugate.
    Sun Q; Jiang S; Han B; Sun T; Li Z; Zhao L; Gao Q; Sun J
    Biochem Biophys Res Commun; 2012 Nov; 427(4):711-7. PubMed ID: 23036194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of the antigenic epitopes in staphylococcal enterotoxins A and E and design of a superantigen for human cancer therapy.
    Erlandsson E; Andersson K; Cavallin A; Nilsson A; Larsson-Lorek U; Niss U; Sjöberg A; Wallén-Ohman M; Antonsson P; Walse B; Forsberg G
    J Mol Biol; 2003 Nov; 333(5):893-905. PubMed ID: 14583188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular analysis of staphylococcal superantigens.
    Schlievert PM; Case LC
    Methods Mol Biol; 2007; 391():113-26. PubMed ID: 18025673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes.
    See RH; Krystal G; Chow AW
    Can J Microbiol; 1992 Sep; 38(9):937-44. PubMed ID: 1281444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective induction of rheumatoid factors by superantigens and human helper T cells.
    He XW; Goronzy J; Weyand C
    J Clin Invest; 1992 Feb; 89(2):673-80. PubMed ID: 1371126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.
    D'Orazio JA; Stein-Streilein J
    Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
    Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
    Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes.
    Phillips JH; Gumperz JE; Parham P; Lanier LL
    Science; 1995 Apr; 268(5209):403-5. PubMed ID: 7716542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
    Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
    J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of T cells by superantigen in class II-negative mice.
    Avery AC; Markowitz JS; Grusby MJ; Glimcher LH; Cantor H
    J Immunol; 1994 Dec; 153(11):4853-61. PubMed ID: 7963549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.